Gene Page: PRMT1
Summary ?
GeneID | 3276 |
Symbol | PRMT1 |
Synonyms | ANM1|HCP1|HRMT1L2|IR1B4 |
Description | protein arginine methyltransferase 1 |
Reference | MIM:602950|HGNC:HGNC:5187|Ensembl:ENSG00000126457|HPRD:04257|Vega:OTTHUMG00000167568 |
Gene type | protein-coding |
Map location | 19q13.3 |
Pascal p-value | 1.215E-5 |
Sherlock p-value | 8.185E-5 |
Fetal beta | 0.678 |
eGene | Caudate basal ganglia Myers' cis & trans |
Support | Chromatin Remodeling Genes |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs443832 | chr16 | 83779643 | PRMT1 | 3276 | 0.15 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)

Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
AR | AIS | DHTR | HUMARA | KD | NR3C4 | SBMA | SMAX1 | TFM | androgen receptor | Reconstituted Complex | BioGRID | 11050077 |
ARPC3 | ARC21 | p21-Arc | actin related protein 2/3 complex, subunit 3, 21kDa | Two-hybrid | BioGRID | 16169070 |
BTG1 | - | B-cell translocation gene 1, anti-proliferative | Reconstituted Complex Two-hybrid | BioGRID | 8663146 |11856371 |
BTG1 | - | B-cell translocation gene 1, anti-proliferative | BTG1 interacts with HRMT1L2 (PRMT1). This interaction was modeled on a demonstrated interaction between human BTG1 and PRMT1 from an unspecified species. | BIND | 15674337 |
BTG1 | - | B-cell translocation gene 1, anti-proliferative | - | HPRD | 8663146 |14734530 |
BTG2 | MGC126063 | MGC126064 | PC3 | TIS21 | BTG family, member 2 | - | HPRD,BioGRID | 11856371 |
BTG2 | MGC126063 | MGC126064 | PC3 | TIS21 | BTG family, member 2 | - | HPRD | 8663146 |11856371|11856371 |
C1orf103 | FLJ11269 | RIF1 | RP11-96K19.1 | chromosome 1 open reading frame 103 | Two-hybrid | BioGRID | 16169070 |
CAPRIN1 | GPIAP1 | GPIP137 | M11S1 | caprin-1 | p137GPI | cell cycle associated protein 1 | Biochemical Activity | BioGRID | 12183049 |
CARM1 | PRMT4 | coactivator-associated arginine methyltransferase 1 | Phenotypic Enhancement | BioGRID | 11050077 |
CIRBP | CIRP | cold inducible RNA binding protein | - | HPRD,BioGRID | 11850402 |
DHX9 | DDX9 | LKP | NDHII | RHA | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | - | HPRD,BioGRID | 11850402 |15084609 |
ESR1 | DKFZp686N23123 | ER | ESR | ESRA | Era | NR3A1 | estrogen receptor 1 | Reconstituted Complex | BioGRID | 11050077 |
FBL | FIB | FLRN | RNU3IP1 | fibrillarin | - | HPRD,BioGRID | 14583623 |
FUS | CHOP | FUS-CHOP | FUS1 | TLS | TLS/CHOP | hnRNP-P2 | fusion (involved in t(12;16) in malignant liposarcoma) | - | HPRD,BioGRID | 11850402 |
HABP4 | IHABP4 | Ki-1/57 | MGC825 | SERBP1L | hyaluronan binding protein 4 | Two-hybrid | BioGRID | 16169070 |
HNRNPA1 | HNRPA1 | MGC102835 | heterogeneous nuclear ribonucleoprotein A1 | Biochemical Activity | BioGRID | 8663146 |
HNRNPK | CSBP | FLJ41122 | HNRPK | TUNP | heterogeneous nuclear ribonucleoprotein K | - | HPRD,BioGRID | 12529443 |
HNRNPR | FLJ25714 | HNRPR | hnRNP-R | heterogeneous nuclear ribonucleoprotein R | - | HPRD,BioGRID | 12183049 |
HNRNPU | HNRPU | SAF-A | U21.1 | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | - | HPRD,BioGRID | 11850402 |
HNRNPUL1 | E1B-AP5 | E1BAP5 | FLJ12944 | HNRPUL1 | heterogeneous nuclear ribonucleoprotein U-like 1 | Biochemical Activity | BioGRID | 11513728 |
IFNAR1 | AVP | IFN-alpha-REC | IFNAR | IFNBR | IFRC | interferon (alpha, beta and omega) receptor 1 | - | HPRD,BioGRID | 9029147 |
IGSF21 | FLJ41177 | MGC15730 | immunoglobin superfamily, member 21 | Two-hybrid | BioGRID | 16169070 |
ILF3 | CBTF | DRBF | DRBP76 | MMP4 | MPHOSPH4 | MPP4 | NF-AT-90 | NF110 | NF90 | NFAR | NFAR-1 | NFAR2 | TCP110 | TCP80 | interleukin enhancer binding factor 3, 90kDa | - | HPRD,BioGRID | 10749851 |
KHDRBS1 | FLJ34027 | Sam68 | p62 | KH domain containing, RNA binding, signal transduction associated 1 | - | HPRD,BioGRID | 12529443 |
KHDRBS3 | Etle | SALP | SLM-2 | SLM2 | T-STAR | TSTAR | etoile | KH domain containing, RNA binding, signal transduction associated 3 | - | HPRD,BioGRID | 12529443 |
MED31 | 3110004H13Rik | CGI-125 | FLJ27436 | FLJ36714 | Soh1 | mediator complex subunit 31 | Two-hybrid | BioGRID | 16169070 |
NCOA1 | F-SRC-1 | KAT13A | MGC129719 | MGC129720 | NCoA-1 | RIP160 | SRC-1 | SRC1 | bHLHe42 | nuclear receptor coactivator 1 | - | HPRD,BioGRID | 11050077 |
NCOA2 | GRIP1 | KAT13C | MGC138808 | NCoA-2 | TIF2 | nuclear receptor coactivator 2 | - | HPRD,BioGRID | 11050077 |
NCOA3 | ACTR | AIB-1 | AIB1 | CAGH16 | CTG26 | KAT13B | MGC141848 | RAC3 | SRC3 | TNRC14 | TNRC16 | TRAM-1 | pCIP | nuclear receptor coactivator 3 | - | HPRD,BioGRID | 11050077 |
PRMT1 | ANM1 | HCP1 | HRMT1L2 | IR1B4 | protein arginine methyltransferase 1 | - | HPRD,BioGRID | 12737817 |
QKI | DKFZp586I0923 | Hqk | QK | QK1 | QK3 | quaking homolog, KH domain RNA binding (mouse) | - | HPRD | 12529443 |
S100A8 | 60B8AG | CAGA | CFAG | CGLA | CP-10 | L1Ag | MA387 | MIF | MRP8 | NIF | P8 | S100 calcium binding protein A8 | Two-hybrid | BioGRID | 16169070 |
SSSCA1 | p27 | Sjogren syndrome/scleroderma autoantigen 1 | Affinity Capture-MS | BioGRID | 17353931 |
SUPT5H | FLJ34157 | SPT5 | SPT5H | suppressor of Ty 5 homolog (S. cerevisiae) | - | HPRD,BioGRID | 12718890 |
SYNCRIP | GRY-RBP | HNRPQ1 | NSAP1 | RP1-3J17.2 | dJ3J17.2 | hnRNP-Q | pp68 | synaptotagmin binding, cytoplasmic RNA interacting protein | Biochemical Activity | BioGRID | 12183049 |
TAF15 | Npl3 | RBP56 | TAF2N | TAFII68 | hTAFII68 | TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa | Biochemical Activity | BioGRID | 12183049 |
THRB | ERBA-BETA | ERBA2 | GRTH | MGC126109 | MGC126110 | NR1A2 | PRTH | THR1 | THRB1 | THRB2 | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | Reconstituted Complex | BioGRID | 11050077 |
TP53 | FLJ92943 | LFS1 | TRP53 | p53 | tumor protein p53 | - | HPRD,BioGRID | 15186775 |
TP53 | FLJ92943 | LFS1 | TRP53 | p53 | tumor protein p53 | PRMT1 interacts with p53. This interaction was modeled on a demonstrated interaction between rat PRMT1 and human p53. | BIND | 15186775 |
WDR33 | FLJ11294 | WDC146 | WD repeat domain 33 | Two-hybrid | BioGRID | 16169070 |
YLPM1 | C14orf170 | ZAP | ZAP3 | YLP motif containing 1 | Two-hybrid | BioGRID | 16169070 |
ZFP161 | MGC126126 | ZBTB14 | ZF5 | ZNF478 | zinc finger protein 161 homolog (mouse) | Biochemical Activity | BioGRID | 12183049 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
PID P53 DOWNSTREAM PATHWAY | 137 | 94 | All SZGR 2.0 genes in this pathway |
LIU SOX4 TARGETS DN | 309 | 191 | All SZGR 2.0 genes in this pathway |
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | 1382 | 904 | All SZGR 2.0 genes in this pathway |
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA UP | 368 | 234 | All SZGR 2.0 genes in this pathway |
VECCHI GASTRIC CANCER EARLY UP | 430 | 232 | All SZGR 2.0 genes in this pathway |
RHEIN ALL GLUCOCORTICOID THERAPY DN | 362 | 238 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA DN | 1375 | 806 | All SZGR 2.0 genes in this pathway |
HAHTOLA MYCOSIS FUNGOIDES DN | 16 | 10 | All SZGR 2.0 genes in this pathway |
PROVENZANI METASTASIS DN | 136 | 94 | All SZGR 2.0 genes in this pathway |
SCHLOSSER MYC TARGETS AND SERUM RESPONSE UP | 47 | 32 | All SZGR 2.0 genes in this pathway |
MOHANKUMAR TLX1 TARGETS UP | 414 | 287 | All SZGR 2.0 genes in this pathway |
TSAI RESPONSE TO IONIZING RADIATION | 149 | 101 | All SZGR 2.0 genes in this pathway |
PUJANA BRCA1 PCC NETWORK | 1652 | 1023 | All SZGR 2.0 genes in this pathway |
PUJANA CHEK2 PCC NETWORK | 779 | 480 | All SZGR 2.0 genes in this pathway |
NUYTTEN EZH2 TARGETS DN | 1024 | 594 | All SZGR 2.0 genes in this pathway |
WEI MYCN TARGETS WITH E BOX | 795 | 478 | All SZGR 2.0 genes in this pathway |
RICKMAN TUMOR DIFFERENTIATED MODERATELY VS POORLY UP | 121 | 71 | All SZGR 2.0 genes in this pathway |
SCHAEFFER PROSTATE DEVELOPMENT 12HR DN | 57 | 45 | All SZGR 2.0 genes in this pathway |
PENG LEUCINE DEPRIVATION DN | 187 | 122 | All SZGR 2.0 genes in this pathway |
FLECHNER PBL KIDNEY TRANSPLANT OK VS DONOR UP | 151 | 100 | All SZGR 2.0 genes in this pathway |
SANA RESPONSE TO IFNG DN | 85 | 56 | All SZGR 2.0 genes in this pathway |
PENG RAPAMYCIN RESPONSE DN | 245 | 154 | All SZGR 2.0 genes in this pathway |
PENG GLUTAMINE DEPRIVATION DN | 337 | 230 | All SZGR 2.0 genes in this pathway |
MATSUDA NATURAL KILLER DIFFERENTIATION | 475 | 313 | All SZGR 2.0 genes in this pathway |
HESS TARGETS OF HOXA9 AND MEIS1 UP | 65 | 44 | All SZGR 2.0 genes in this pathway |
XU CREBBP TARGETS UP | 26 | 16 | All SZGR 2.0 genes in this pathway |
XU RESPONSE TO TRETINOIN AND NSC682994 DN | 15 | 12 | All SZGR 2.0 genes in this pathway |
BLALOCK ALZHEIMERS DISEASE DN | 1237 | 837 | All SZGR 2.0 genes in this pathway |
RAMASWAMY METASTASIS UP | 66 | 43 | All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 6HR UP | 953 | 554 | All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 24HR DN | 1011 | 592 | All SZGR 2.0 genes in this pathway |
KYNG DNA DAMAGE BY 4NQO OR UV | 63 | 44 | All SZGR 2.0 genes in this pathway |
KYNG DNA DAMAGE DN | 195 | 135 | All SZGR 2.0 genes in this pathway |
STEARMAN LUNG CANCER EARLY VS LATE UP | 125 | 89 | All SZGR 2.0 genes in this pathway |
RIZKI TUMOR INVASIVENESS 3D DN | 270 | 181 | All SZGR 2.0 genes in this pathway |
GRADE METASTASIS DN | 45 | 31 | All SZGR 2.0 genes in this pathway |
LABBE WNT3A TARGETS UP | 112 | 71 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER SURVIVAL DN | 175 | 103 | All SZGR 2.0 genes in this pathway |
AGUIRRE PANCREATIC CANCER COPY NUMBER UP | 298 | 174 | All SZGR 2.0 genes in this pathway |
LEE RECENT THYMIC EMIGRANT | 227 | 128 | All SZGR 2.0 genes in this pathway |
SHEDDEN LUNG CANCER POOR SURVIVAL A6 | 456 | 285 | All SZGR 2.0 genes in this pathway |
CAIRO HEPATOBLASTOMA CLASSES UP | 605 | 377 | All SZGR 2.0 genes in this pathway |
WONG EMBRYONIC STEM CELL CORE | 335 | 193 | All SZGR 2.0 genes in this pathway |
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 14 | 143 | 86 | All SZGR 2.0 genes in this pathway |
MARTENS TRETINOIN RESPONSE DN | 841 | 431 | All SZGR 2.0 genes in this pathway |
LEE BMP2 TARGETS DN | 882 | 538 | All SZGR 2.0 genes in this pathway |